Research Topic · Peer-Reviewed

Suicide

gene therapy Suicide gene therapy is an emerging field of gene therapy aimed at treating cancer and other genetic diseases. The goal of this type of gene therapy is to introduce a gene known as the “suicide gene” into the patient's cells which can be activated by exposure to a certain drug. When the gene is activat…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 48× across the literature 🗓 Reviewed June 2026

Overview

gene therapy Suicide gene therapy is an emerging field of gene therapy aimed at treating cancer and other genetic diseases. The goal of this type of gene therapy is to introduce a gene known as the “suicide gene” into the patient's cells which can be activated by exposure to a certain drug. When the gene is activated, it sends a signal for the cell to self-destruct thereby selectively killing the cancer cells and leaving the healthy cells intact. This type of therapy may eventually offer a more targeted and effective cancer treatment than current therapies, such as chemotherapy and radiation. It may also be used to treat other genetic diseases, such as cystic fibrosis, Huntington disease, and sickle cell anemia.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 48 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Suicide, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Schizophrenia Disorders And Therapy.

Journal editorial board
Olaoluwa Okusaga · United States Andrea de Bartolomeis · Italy Krzysztof Krysta · Poland

This page summarises published research for orientation; it is not medical or professional advice.